Search
Isoxaflutole
go.drugbank.com/drugs/DB12938ApprovedWithdrawnBalance has been investigated for the treatment of Chronic Renal Failure and Peritoneal Membrane Disorder.
Zafiride
go.drugbank.com/drugs/DB18371InvestigationalZafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.
5-fluorotryptophan
go.drugbank.com/drugs/DB03314Experimental5-fluorotryptophan can be used as substrate analogue to study enzyme mechanisms by NMR spectroscopy.
Uridine-5'-Diphosphate
go.drugbank.com/drugs/DB03435ExperimentalA uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem]
Indium In-111 pentetate
go.drugbank.com/drugs/DB09425ApprovedInvestigationalDecay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column.
Asimadoline
go.drugbank.com/drugs/DB05104InvestigationalAsimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. … It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases.
PN0621
go.drugbank.com/drugs/DB05218ExperimentalIt targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis. It is being developed by Peptech.
Guvacine
go.drugbank.com/drugs/DB08848ExperimentalGuvacine is a pyridine alkaloid found in the Areca nut (also known as the Betel nut). It is an experimental drug with no approved indication. … Experimental studies are still being investigated to determine all of the physiological effects and mechanisms of action of guvacine.
Mirococept
go.drugbank.com/drugs/DB06492ExperimentalIt is a truncated form of the human Complement Receptor 1 (CR1) linked to a unique Prodaptin™ construct that regulates the over-production of complement at the cell surface, which occurs in inflammation … It consists of the first three short consensus domains of human complement receptor 1 (CR1), manufactured in recombinant bacteria and modified with a membrane-targeting amphiphilic peptide based on the
Palifosfamide
go.drugbank.com/drugs/DB05668InvestigationalIfosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.